Interestingly, the CTX-treated CRC cell line displayed a senescence phenotype, and conversely, IL-1 neutralization was able to revert the CTX-resistant cells into a senescence-mediated growth arrest (Romaniello et al., 2022). Here, IL1A is linked to colorectal carcinoma.